The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ranking neoantigens for escape-resilience rather than predicted immunogenicity: Associated changes in vaccine design.
 
Michael Bryan
Employment - Serova
Leadership - Serova
Stock and Other Ownership Interests - Serova
 
Miles Weatherseed
No Relationships to Disclose
 
Om Gandhi
No Relationships to Disclose
 
Will Ince
Honoraria - Astellas Pharma; AstraZeneca (AZ); Eisai; Ipsen; Merck; Recordati
 
Dimitris Vavoulis
No Relationships to Disclose
 
Anna Schuh
Stock and Other Ownership Interests - Illumina; SERENOx
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen; Roche
Research Funding - Illumina (Inst); Johnson & Johnson; Oxford Nanopore Technologies (Inst)
Travel, Accommodations, Expenses - Abbvie; Janssen Oncology
 
Siow Ming Lee
Leadership - Member, Oncology and Haematology Expert Advisory Group; Member, UK Commission on Human Medicines
 
Eleni Adamopoulou
No Relationships to Disclose
 
Robert Watson
Consulting or Advisory Role - Ellison Institute of Technology, Oxford
 
Richard Mair
No Relationships to Disclose
 
Carol Leung
No Relationships to Disclose
 
Lennard Lee
Employment - Ellison Institute of Technology, Oxford
 
Tim Elliott
Other Relationship - Editor-in-Chief of Immunotherapy Advances.